Atlas Venture Reports 17% Stake in DYN

JC Parets
December 15, 2022

The largest insider buy on today’s list comes in a Form 4 filing by the early stage life sciences investment firm Atlas Venture.

The venture capital fund now owns a total stake in Dyne Therapeutics $DYN of more than 17%.

Here’s The Hot List, with data through December 14, 2022:

In another Form 4, Opaleye Management Inc reported the purchase of 431,183 shares, equivalent to $4.5 million worth of Harrow Health $HROW.

There was also insider activity in FB Financial Corporation $FBK, GoHealth $GOCO and Cronos Group $CRON.

Last but not least, there was bullish options flow in Kimberly-Clark Corp $KMB and Floor & Decor Holdings $FND.

Stay tuned. We'll be back on Friday with more insider activity.

If you want these insider transactions e-mailed to you every morning, click here to sign up for The Hot Corner.

And please reach out with any questions. We love hearing from you!

All Star Charts Team

Filed Under: